Page last updated: 2024-09-03

cyclic adp-ribose and Neoplasms

cyclic adp-ribose has been researched along with Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Gao, W; Huang, C; Huber, PE; Li, C; Shen, G; Xie, N; Zhang, L; Zhou, X; Zou, B	1
Choi, BH; Lee, H; Lee, JK; Lee, JS; Oh, ET; Park, HJ; Park, MT	1
Ausiello, CM; Chillemi, A; Faini, AC; Horenstein, AL; Malavasi, F; Mariani, V; Morandi, F; Quarona, V; Schiavoni, I; Zito, A	1
Forouhar, F; Khan, JA; Tao, X; Tong, L	1

Reviews

3 review(s) available for cyclic adp-ribose and Neoplasms

Article	Year
NAD Signal transduction and targeted therapy, 2020, 10-07, Volume: 5, Issue:1 Topics: Aging; Cyclic ADP-Ribose; Humans; Metabolic Diseases; NAD; NADP; Neoplasms; Neurodegenerative Diseases; Oxidation-Reduction	2020
Antibody mimicry, receptors and clinical applications. Human antibodies, 2017, Volume: 25, Issue:3-4 Topics: ADP-ribosyl Cyclase 1; Allosteric Regulation; Animals; Antibodies, Monoclonal; Antibody Specificity; Cyclic ADP-Ribose; Humans; Immunoglobulin Fab Fragments; Immunoglobulin Fc Fragments; Immunologic Factors; Ligands; Molecular Mimicry; Neoplasms; Protein Binding; Receptor Cross-Talk; Receptors, Antigen, T-Cell; T-Lymphocytes	2017
Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery. Expert opinion on therapeutic targets, 2007, Volume: 11, Issue:5 Topics: Acrylamides; Adenosine Diphosphate Ribose; Aging; Animals; Antineoplastic Agents; Autoimmune Diseases; Clinical Trials, Phase II as Topic; Cyclic ADP-Ribose; DNA Damage; Drug Design; Enzyme Inhibitors; Humans; Kynurenine; Mice; NAD; Neoplasms; Neurodegenerative Diseases; Neuroprotective Agents; Piperidines; Poly Adenosine Diphosphate Ribose; Signal Transduction; Sirtuins; Tryptophan	2007

Other Studies

1 other study(ies) available for cyclic adp-ribose and Neoplasms

Article	Year
NQO1-induced activation of AMPK contributes to cancer cell death by oxygen-glucose deprivation. Scientific reports, 2015, Jan-14, Volume: 5 Topics: ADP-ribosyl Cyclase 1; AMP-Activated Protein Kinases; Animals; Calcium; Calcium Channel Blockers; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Death; Cell Line, Tumor; Cyclic ADP-Ribose; Enzyme Activation; Glucose; Humans; Mice; Models, Biological; NAD; NAD(P)H Dehydrogenase (Quinone); Neoplasms; Oxygen; Phosphorylation; RNA, Small Interfering	2015

Article

Year

NQO1-induced activation of AMPK contributes to cancer cell death by oxygen-glucose deprivation.

Scientific reports, 2015, Jan-14, Volume: 5

Topics: ADP-ribosyl Cyclase 1; AMP-Activated Protein Kinases; Animals; Calcium; Calcium Channel Blockers; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Death; Cell Line, Tumor; Cyclic ADP-Ribose; Enzyme Activation; Glucose; Humans; Mice; Models, Biological; NAD; NAD(P)H Dehydrogenase (Quinone); Neoplasms; Oxygen; Phosphorylation; RNA, Small Interfering

2015